U.S. market Closed. Opens in 11 hours 30 minutes

RLYB | Rallybio Corporation Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue150.00K167.00K109.00K62.03K26.34K
Gross Profit-150.00K-167.00K-109.00K-62.03K-26.34K
Operating Expenses78.78M67.88M45.65M25.30M17.64M
Selling, General & Admin25.39M27.20M18.74M7.67M6.28M
Research & Development53.39M40.69M26.91M17.63M11.37M
Other Operating ExpensesN/A342.00K96.00K241.00K24.00K
Operating Income-78.93M-67.88M-45.65M-25.30M-17.64M
Other Expenses / Income6.41M2.31M140.00K363.00K182.00K
Before Tax Income-72.52M-65.58M-45.51M-24.94M-17.46M
Income Tax Expenses2.04M908.00K1.50M-15.00K166.00K
Net Income-74.56M-66.49M-47.01M-24.93M-17.63M
Interest ExpensesN/A-2.31M10.00K49.00K39.00K
Basic Shares Outstanding40.45M31.82M32.13M32.13M32.13M
Diluted Shares Outstanding40.45M31.82M32.13M32.13M32.13M
EBITDA-78.78M-65.58M-45.50M-24.83M-17.39M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-72.52M-67.88M-45.50M-24.89M-17.42M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙